Home
About
Overview
Sharing Data
ORCID
Help
History (8)
Niacinamide
Octamer Transcription Factor-3
Isoflurane inhibits the neurotransmitter release machinery.
Triple negative breast cancer in BRCA1 mutation carriers with a complete radiologic response to neoadjuvant paclitaxel: a case report.
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.
See All 8 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study.
Pembrolizumab in Patients With Advanced Triple-Negative Breast Cancer: Phase Ib KEYNOTE-012 Study. J Clin Oncol. 2016 07 20; 34(21):2460-7.
View in:
PubMed
subject areas
Adult
Aged
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Female
Humans
L-Lactate Dehydrogenase
Middle Aged
Triple Negative Breast Neoplasms
authors with profiles
Rita Nanda